0.99
price up icon11.56%   0.1026
after-market アフターアワーズ: .99
loading

Verrica Pharmaceuticals Inc (VRCA) 最新ニュース

pulisher
Nov 21, 2024

Verrica Prices of $42 Million Public Offering - citybiz

Nov 21, 2024
pulisher
Nov 21, 2024

VRCAVerrica Pharmaceuticals Inc. Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Verrica Announces Pricing of $42.0 Million Public Offering - GlobeNewswire

Nov 21, 2024
pulisher
Nov 21, 2024

Verrica Pharmaceuticals Raises $42M Through Public Offering of Shares and Warrants | VRCA Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 20, 2024

Form 424B5 Verrica Pharmaceuticals - StreetInsider.com

Nov 20, 2024
pulisher
Nov 20, 2024

Verrica Pharmaceuticals announces proposed public offering - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Verrica Announces Proposed Public Offering - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Verrica Pharmaceuticals Announces Public Offering of Stock and Warrants with Jefferies | VRCA Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Verrica Pharmaceuticals Reports Q3 2024 Financials and Restructuring Plans - MSN

Nov 20, 2024
pulisher
Nov 15, 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Nov 15, 2024
pulisher
Nov 13, 2024

Verrica Pharmaceuticals' SWOT analysis: navigating challenges in dermatology stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Verrica Pharmaceuticals' SWOT analysis: navigating challenges in dermatology stock By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

Q1 Earnings Forecast for VRCA Issued By HC Wainwright - Defense World

Nov 12, 2024
pulisher
Nov 10, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Cut to “Neutral” at HC Wainwright - Defense World

Nov 10, 2024
pulisher
Nov 10, 2024

Verrica downgraded to sector perform by RBC Capital - MSN

Nov 10, 2024
pulisher
Nov 09, 2024

Verrica Pharmaceuticals’ (VRCA) Hold Rating Reaffirmed at Needham & Company LLC - Defense World

Nov 09, 2024
pulisher
Nov 08, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Verrica Pharmaceuticals Announces Leadership Transition and Financial Results for Q3 2024 - Defense World

Nov 07, 2024
pulisher
Nov 06, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Cut to "Neutral" at HC Wainwright - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

RBC Capital Downgrades Verrica Pharmaceuticals (VRCA) - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals Reports Q3 2024 EPS of -$0.49 and Revenue of -$1.9 Million, Misses Estimates - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals stock hits 52-week low at $0.93 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

U.S. Stock market: Bluejay Diagnostics (+105.33%), Zoomcar Holdings (+180.40%), and Verrica Pharmaceuticals(+39.10%) among the most volatile stocks during mid day trading - Business Upturn

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals stock hits 52-week low at $0.93 By Investing.com - Investing.com South Africa

Nov 05, 2024
pulisher
Nov 05, 2024

U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn

Nov 05, 2024
pulisher
Nov 05, 2024

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September - Benzinga

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Releases Quarterly Earnings Results - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded to Sector Perform Rating by Royal Bank of Canada - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Verrica Pharmaceuticals Appoints Jayson Rieger as New CEO - Marketscreener.com

Nov 05, 2024
pulisher
Nov 04, 2024

Verrica Pharmaceuticals earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada

Nov 04, 2024
pulisher
Nov 04, 2024

Shares of Verrica Pharmaceuticals Tumble Following 3Q Results, Operational Changes - MarketWatch

Nov 04, 2024
pulisher
Nov 04, 2024

Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership - The Bakersfield Californian

Nov 04, 2024
pulisher
Nov 04, 2024

Verrica Pharmaceuticals Undergoes Leadership and Financial Restructuring - TipRanks

Nov 04, 2024
pulisher
Nov 04, 2024

Botanix Pharmaceuticals Poised for Market Impact with Sofdra Launch - MSN

Nov 04, 2024
pulisher
Oct 30, 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update - Defense World

Oct 30, 2024
pulisher
Oct 28, 2024

Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Expands By 24.8% - MarketBeat

Oct 28, 2024
pulisher
Oct 24, 2024

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference - GlobeNewswire

Oct 24, 2024
pulisher
Oct 22, 2024

Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection - Law360

Oct 22, 2024
pulisher
Oct 21, 2024

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Verrica Pharmaceuticals (NASDAQ:VRCA) Given New $10.00 Price Target at TD Cowen - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Verrica shares price target cut by TD Cowen - Investing.com Canada

Oct 21, 2024
pulisher
Oct 11, 2024

VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc.VRCA - Business Wire

Oct 11, 2024
pulisher
Oct 10, 2024

GLP-1 Receptor Agonist Market Set to Witness Significant Growth by 2024-2031:Verrica Pharmaceuticals, AbbVie - EIN News

Oct 10, 2024
pulisher
Oct 09, 2024

Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Verrica Pharmaceuticals reports board changes, non-compliance - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

Verrica Pharmaceuticals reports board changes, non-compliance By Investing.com - Investing.com Australia

Oct 09, 2024
pulisher
Oct 08, 2024

Recent Insider Activity Could Benefit Verrica Pharmaceuticals Inc (VRCA) - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Verrica Pharmaceuticals Strives for Nasdaq Compliance - TipRanks

Oct 08, 2024
pulisher
Oct 07, 2024

Optinose Names Terry Kohler as CFO - MarketWatch

Oct 07, 2024
pulisher
Oct 07, 2024

Optinose names Terry Kohler as new CFO By Investing.com - Investing.com UK

Oct 07, 2024
pulisher
Oct 07, 2024

Optinose Appoints Terry Kohler as Chief Financial Officer - Marketscreener.com

Oct 07, 2024
pulisher
Oct 07, 2024

The Significance of Moving Averages in Verrica Pharmaceuticals Inc Inc. (VRCA) Price Performance - The InvestChronicle

Oct 07, 2024
pulisher
Oct 07, 2024

Verrica Pharmaceuticals Inc (VRCA)’s stock price range in the last year - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

Financial Fitness Check: Examining Verrica Pharmaceuticals Inc (VRCA)’s Key Ratios - The Dwinnex

Oct 07, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):